Key Points
- Major shareholder Clark Crosnoe sold 550,701 shares at an average of $2.32 for a total of $1,277,626.32, leaving him with 17,875 shares — a 96.86% reduction in his stake.
- cbdMD shares opened at $1.51 and trade within a 12‑month range of $0.47 to $6.54, with the 50‑day and 200‑day moving averages near $0.89 and $0.88 respectively.
- Institutional investor Chapin Davis boosted its position by 62.5% to 118,626 shares (about 1.33% ownership), and institutions/hedge funds own roughly 7.18% of the stock.
cbdMD, Inc. (NYSEAMERICAN:YCBD - Get Free Report) major shareholder Clark Crosnoe sold 550,701 shares of cbdMD stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $2.32, for a total value of $1,277,626.32. Following the completion of the transaction, the insider directly owned 17,875 shares of the company's stock, valued at $41,470. This represents a 96.86% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.
cbdMD Price Performance
Shares of NYSEAMERICAN:YCBD opened at $1.51 on Friday. cbdMD, Inc. has a 12 month low of $0.47 and a 12 month high of $6.54. The company's 50-day moving average price is $0.89 and its two-hundred day moving average price is $0.88.
Institutional Trading of cbdMD
An institutional investor recently raised its position in cbdMD stock. Chapin Davis Inc. boosted its position in shares of cbdMD, Inc. (NYSEAMERICAN:YCBD - Free Report) by 62.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 118,626 shares of the company's stock after buying an additional 45,626 shares during the quarter. Chapin Davis Inc. owned approximately 1.33% of cbdMD worth $106,000 as of its most recent SEC filing. 7.18% of the stock is currently owned by institutional investors and hedge funds.
About cbdMD
(
Get Free Report)
cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.
The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
